These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 9748534)
1. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534 [TBL] [Abstract][Full Text] [Related]
2. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066 [TBL] [Abstract][Full Text] [Related]
3. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice. Zimmer DM; Harbach PR; Mattes WB; Aaron CS Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627 [TBL] [Abstract][Full Text] [Related]
4. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Walker VE; Sisk SC; Upton PB; Wong BA; Recio L Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020 [TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity. Recio L; Saranko CJ; Steen AM Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839 [TBL] [Abstract][Full Text] [Related]
6. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats. Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020 [TBL] [Abstract][Full Text] [Related]
7. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980 [TBL] [Abstract][Full Text] [Related]
8. Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice. Skopek TR; Kort KL; Marino DR Environ Mol Mutagen; 1995; 26(1):9-15. PubMed ID: 7641713 [TBL] [Abstract][Full Text] [Related]
9. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice. Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479 [TBL] [Abstract][Full Text] [Related]
10. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice. Walker VE; Andrews JL; Upton PB; Skopek TR; deBoer JG; Walker DM; Shi X; Sussman HE; Gorelick NJ Environ Mol Mutagen; 1999; 34(2-3):167-81. PubMed ID: 10529741 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene. Davies R; Gant TW; Smith LL; Styles JA Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts. Watson DE; Cunningham ML; Tindall KR Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194 [TBL] [Abstract][Full Text] [Related]
13. Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue(R) rats treated with 7, 12-dimethylbenz[a]anthracene. Manjanatha MG; Shelton SD; Aidoo A; Lyn-Cook LE; Casciano DA Mutat Res; 1998 Jun; 401(1-2):165-78. PubMed ID: 9639698 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040 [TBL] [Abstract][Full Text] [Related]
15. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771 [TBL] [Abstract][Full Text] [Related]
16. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. Shane BS; Lockhart AM; Winston GW; Tindall KR Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573 [TBL] [Abstract][Full Text] [Related]
17. Gene- and tissue-specificity of mutation in Big Blue rats treated with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene. Chen T; Mittelstaedt RA; Shelton SD; Dass SB; Manjanatha MG; Casciano DA; Heflich RH Environ Mol Mutagen; 2001; 37(3):203-14. PubMed ID: 11317338 [TBL] [Abstract][Full Text] [Related]
18. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice. Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067 [TBL] [Abstract][Full Text] [Related]
19. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats. Chen T; Mittelstaedt RA; Aidoo A; Hamilton LP; Beland FA; Casciano DA; Heflich RH Environ Mol Mutagen; 2001; 37(3):195-202. PubMed ID: 11317337 [TBL] [Abstract][Full Text] [Related]
20. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1. Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]